The role of apoptosis in the initiation of the autoimmune response in Sjogren's syndrome

Clinical and Experimental Immunology

Volumn 116, Issue 3, 1999, Pages 383-387

  Humphreys Beher, Michael G ^a,d   Peck, A B ^b   Dang, H ^c   Talal, N ^c  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c University of Texas Medical Center ^*  (United States)

^d UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; CELL ACTIVATION; DIAGNOSTIC APPROACH ROUTE; DISEASE COURSE; GENE EXPRESSION; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOPATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REVIEW; SJOEGREN SYNDROME;

ANIMALS; APOPTOSIS; AUTOIMMUNITY; DISEASE MODELS, ANIMAL; HUMANS; PROTO-ONCOGENE PROTEINS C-BCL-2; SJOGREN'S SYNDROME;

EID: 0033026546     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1999.00888.x     Document Type: Review

References (38)

1. Mountz JD, Talal N. Retroviruses, apoptosis and autoantigens. Immunol Today 1993; 14:532-6.
2. Fox RI, Kang H-I. Pathogenesis of Sjögren's syndrome. Rheum Dis Clin N Am 1992; 18:517-38.
3. Ogawa N, Dang H, Talal N. Apoptosis and autoimmunity. J Autoimmun 1995; 8:1-20.
4. Talal N, Sjögren's syndrome: historical overview and clinical spectrum of disease. Rheum Dis Clin N Am 1992; 18:507-16.
5. Kong L, Robinson CP, Peck AB et al. Excessive apoptosis of salivary and lacrimal gland epithelium of immunodeficient NOD-scid mice. Clin Exp Rheumatol 1998; 16:675-82.
6. null mice reveals a role for autoantibodies in the loss of secretory function of exocrine tissues in Sjögren's syndrome. Proc Natl Acad Sci USA 1998; 95:7538-43.
7. Gajewski TF, Thompson CB. Apoptosis meets signal transduction: elimination of a BAD influence. Cell 1996; 87:589-92.
8. Adams JM, Cory S. The Bcl-2 family: arbiters of cell survival. Sci 1998; 281:1322-6.
9. Kong L, Ogawa N, Nakabayashi T et al. Fas and Fas ligand expression in the salivary glands of patients with primary Sjögren's syndrome. Arthritis Rheum 1997; 40:87-97.
10. Jacobson MD, Weil M, Raff MC. Programmed cell death in animal development. Cell 1997; 88:347-54.
11. Kong L, Ogawa N, McGuff SH et al. Bcl-2 family expression in salivary glands from patients with primary Sjögren's syndrome: involvement of Bax in salivary gland destruction. Clin Immunol Immunopathol 1998; 88:133-41.
12. Giordano C, Stassi G, De Maria R et al. Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Sci 1997; 275:960-3.
13. Benoist C, Mathis D. Cell death mediators in autoimmune diabetes - no shortage of suspects. Cell 1997; 89:1-3.
14. Chervonsky AV, Wang Y, Wong FS et al. The role of Fas in autoimmune diabetes. Cell 1997; 89:17-24.
15. Alpert S, Kang H-I, Weissman I, Fox RI. Expression of granzyme A in salivary gland biopsies from patients with primary Sjögren's syndrome. Arthritis Rheum 1994; 37:1046-54.
16. Hu Y, Nakagawa Y, Purushotham KR et al. Functional changes in the salivary glands of autoimmune disease-prone NOD mice. Am J Physiol 1992; 263:E607-14.
17. Humphreys-Beher MG, Brinkley L, Purushotham KR et al. Characterization of antinuclear autoantibodies present in the serum from non-obese diabetic mice. Clin Immunol Immunopathol 1993; 68:350-6.
18. Nakabayashi T, Letterio JJ, Geiser AG et al. Up-regulation of cytokine mRNA, adhesion molecule proteins, and MHC class II proteins in the salivary glands of TGF-beta 1 knockout mice: MHC class II is a factor in the pathogenesis of TGF-beta 1 knockout mice. J Immunol 1997; 158:5527-35.
19. Skarstein K, Nerland AH, Eidsheim M, Mountz JD, Jonsson R. Lymphoid cell accumulation in salivary glands of autoimmune MRL mice can be due to impaired apoptosis. Scand J Immunol 1997; 46:373-8.
20. Hu Y, Purushotham KR, Wang P et al. Down-regulation of Beta-adrenergic receptors and signal transduction response in salivary glands of NOD mice. Am J Physiol 1994; 266:G433-43.
21. Yamamoto H, Sims NE, Macauley SP et al. Alterations of the secretory response of NOD mice to muscarinic receptor stimulation. Clin Immunol Immunopathol 1996; 78:245-55.
22. Fraser A, Evan G. A license to kill. Cell 1996; 85:781-4.
23. Bell DA. Immunogenic DNA-related factors. Nucleosomes spontaneously released from normal lymphoid cells stimulate proliferation and immunoglobulin synthesis of normal mouse lymphocytes. J Clin Invest 1990; 85:1487-96.
24. Casiola-Rosen LA, Anhalt G, Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 1995; 179:1317-30.
25. Chany EKC, Andrade LEC. Antinuclear antibodies in Sjögren's syndrome. Rheum Dis Clin N Am 1992; 18:551-70.
26. Haneji N, Nakamura T, Takio K et al. Identification of α -fodrin as a candidate autoantigen in primary Sjögren's syndrome. Sci 1997; 276:604-7.
27. Robinson C, Yamamoto H, Peck A et al. Genetically programmed development of salivary gland abnormalities in the NOD mouse: a potential trigger for sialoadenitis of NOD mice. Clin Immunol Immunopathol 1996; 79:50-59.
28. Robinson CP, Yamachika S, Alford CE et al. Elevated levels of cysteine protease activity in saliva and salivary glands of the NOD mouse model for Sjögren's syndrome. Proc Natl Acad Sci USA 1997; 94:5767-71.
29. Yanagi K, Ishimaru N, Haneji N, Sacgusa K, Saito I, Hayashi Y. Anti-120-kDa alpha fodrin immune response with Th1 profile in the NOD mouse model of Sjögren's syndrome. Eur J Immunol 1998; 28:3336-45.
30. Rouslahti E. Stretching is good for a cell. Sci 1997; 276:1345-6.
31. Manganelli P, Quaini F, Andreoli AM et al. Quantitative analysis of apoptosis and bcl-2 in Sjögren's syndrome. J Rheumatol 1997; 24:1552-7.
32. Boise LH, Thompson CB. Hierarchical control of lymphocyte survival. Sci 1996; 274:67-68.
33. Chen CS, Mrksieh M, Huang S et al. Geometrie control of cell life and death. Sci 1997; 276:1425-8.
34. Baeman S, Sterin-Borda L, Jose Camusso J et al. Circulating antibodies against rat parotid gland M3 muscarinic receptors in primary Sjögren's syndrome. Clin Exp Immunol 1996; 104:454-9.
35. Hildebrand A, Romaris M, Rasmussen LM et al. Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. Biochem J 1994; 302:527-34.
36. Flescher E, Vela-Roth N, Ogawa N et al. Abnormality of Oct-1 DNA binding in T cells from Sjögren's syndrome patients. Eur J Immunol 1996; 26:2006-11.
37. Yamachika S, Nanni JM, Nguyen K-IIT et al. Excessive synthesis of matrix metalloproteinase (MMP) activity in exocrine tissues of NOD mouse models for Sjögren's syndrome. J Rheumatol 1998; 25:2371-80.
38. Konttinen YT, Halinen S, Hanemaaijer R et al. Matrix metalloproteinase (MMP)-9 type IV collagenase/gelatinase implicated in the pathogenesis of Sjögren's syndrome. Matrix Biol 1998; 17:335-47.